Exicure, Inc. (XCUR)
1.27
+0.04
(+3.25%)
USD |
NASDAQ |
Sep 04, 11:29
Exicure Cash from Investing (Quarterly) : 0.00 for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.455M |
| September 30, 2025 | 0.108M |
| June 30, 2025 | -0.28M |
| March 31, 2025 | -2.09M |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.711M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | -1.895M |
| March 31, 2023 | 0.106M |
| December 31, 2022 | 0.207M |
| September 30, 2022 | 0.998M |
| June 30, 2022 | 1.496M |
| March 31, 2022 | 1.995M |
| Date | Value |
|---|---|
| December 31, 2021 | 4.108M |
| September 30, 2021 | 4.444M |
| June 30, 2021 | 19.24M |
| March 31, 2021 | 15.30M |
| December 31, 2020 | 13.47M |
| September 30, 2020 | 5.635M |
| June 30, 2020 | 3.538M |
| March 31, 2020 | -12.50M |
| December 31, 2019 | -62.97M |
| September 30, 2019 | -0.40M |
| June 30, 2019 | -0.054M |
| March 31, 2019 | -0.008M |
| December 31, 2018 | -0.029M |
| September 30, 2018 | -0.005M |
| June 30, 2018 | -0.06M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.20M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 0.00 |
| Manhattan Scientifics, Inc. | -- |
| Century Therapeutics, Inc. | 17.77M |
| Absci Corp. | 24.07M |
| Celularity, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.887M |
| Free Cash Flow | -6.385M |
| Free Cash Flow Per Share (Quarterly) | -0.1392 |
| Free Cash Flow to Equity (Quarterly) | -0.865M |
| Free Cash Flow to Firm (Quarterly) | -0.887M |
| Free Cash Flow Yield | -79.04% |